Author:
Greco F. Anthony,Hainsworth John D.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference21 articles.
1. Dombernowsky P, Nissen NI (1973) Schedule dependency of the antileukemic activity of the podophyllotoxin-derivative VP-16-213 in L1210 leukemia. Acta Pathol Microbiol Immunol Scand [A] 81: 715?724
2. Cavalli F, Sonntag RW, Jung F, et al (1978) VP-16-213 monotherapy for remission induction of small cell lung cancer: a randomized trial using three dosage schedules. Cancer Treat Rep 62: 473?475
3. Longo DL, DeVita VT Jr, Duffey PL, et al (1991) Superiority of ProMACE-CytaBom over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma. Results of a prospective, randomized trial. J Clin Oncol 9: 25?38
4. Slevin ML, Clark PI, Joel SP, et al (1989) A randomized trial to evaluate the effect of schedule on the activity of etoposide in small cell lung cancer. J Clin Oncol 7: 1333?1340
5. Abratt RP, Willcox PA, deGroot M, et al (1991) Prospective study of etoposide scheduling in combination chemotherapy for limited stage small cell lung carcinoma. Eur J Cancer Clin Oncol 27: 28?30
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献